BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 17, 2026
Home » Topics » Coronavirus, Medical technology

Coronavirus, Medical technology
Coronavirus, Medical technology RSS Feed RSS

Men reviewing chest X-rays

India looks to AI to tackle TB, COVID-19

Jan. 8, 2021
By T.V. Padma
NEW DELHI – India, which has the highest incidence of tuberculosis (TB) in the world and the second highest of COVID-19, is looking to artificial intelligence (AI) to help detect and classify cases of both and lower the cost of diagnosis.
Read More

Regulatory front for Jan. 8, 2021

Jan. 8, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA formally posts testing advisory after town hall discussion; HHS finalizes regulatory review rule; Lab in California hit for three months of false claims; BVMed calls for German med tech strategy.
Read More

Other news to note for Jan. 8, 2021

Jan. 8, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 4basecare, Applied Biosystems, Applied DNA Sciences, Blue Note Therapeutics, Caredx, Crown Bioscience, Emulate, Labcorp, Myriad Genetics, Pacific Biosciences, Transchart.
Read More

Regulatory actions for Jan. 7, 2021

Jan. 7, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardiowise, Locate Bio, Siemens Healthineers.
Read More

Other news to note for Jan. 7, 2021

Jan. 7, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amptec, Agimed, Apt Medical, Avacta, Caredx, Cellectis, Clear Labs, Daavlin, Ehave, Foracare Suisse, Freedom Ventures, Haliodx, Healthmyne, IDbyDNA, Idt, Immunovia, Infab, Konica Minolta Healthcare, Medallia, Medidrapes, Merck, Milliporesigma, Mirion Technologies, Neuros Medical, Nuvo Group, OncoDNA, Pi-Cardia, Point Biopharma, QT Imaging, Reflexion Medical, Sirion Biotech, Skylight Health Group, Soligenix, Solvd Health, Spectrum Solutions, Steribottle, Sun Nuclear, Theralight, Tidepool, Twist Bioscience, Vericel, Unitedhealthcare.
Read More
Respiratory infection

Nextgen launches trial for rapid breath test to measure COVID-19 vaccine efficacy

Jan. 6, 2021
By Annette Boyle
Nextgen Biomed Ltd. has begun a clinical trial of a breath test to monitor antibody levels in individuals vaccinated against COVID-19. Be'er Ya'akov, Israel-based Shamir Medical Center authorized the trial for test developer Scent Medical Technologies Ltd. (Scentech Medical), which is in the midst of merging with Nextgen. The merged company will be called Scentech Medical.
Read More
Digital illustration of U.S., coronavirus

Stenzel: FDA not in a hurry to address EUA conversion due to persistence of pandemic

Jan. 6, 2021
By Mark McCarty
The U.S. FDA is actively working on guidance for conversion of emergency use authorizations (EUAs) to conventional premarket review programs, but the FDA’s Tim Stenzel said he does “not perceive a need to rush to convert EUAs” because of the volume of EUA applications, and because he does not expect the public health emergency “to end anytime soon.”
Read More

Regulatory front for Jan. 6, 2021

Jan. 6, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA grants EUA to Quanterix for Simoa test; EC investing in startups; Alternatives to animal testing a challenge; USPTO seeks more uniformity between PTAB, courts; NICE nods to Olympus Plasma for BPH.
Read More

Other news to note for Jan. 6, 2021

Jan. 6, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanced Oncotherapy, Apex Family Medical, Bioclinica, Biodesix, Bio-Techne, Biotheranostics, Bioventrix, Carmat, Change Healthcare, Cssi Lifesciences, Diamedcare, Fathom Consulting, Fresenius Kabi, Helix Opco, Helius Medical Technologies, Hologic, Illumina, Medacuity, Monteris Medical, Nephros, Novasep, Optimuminsight, Pointclickcare, Rewalk Robotics, Saliency, Sartorius, Scaleready, Seegene, Sequans Communications, Skylight Health, Tonic Bioventures, Withings, Valgenesis.
Read More

Regulatory front for Jan. 5, 2021

Jan. 5, 2021
By Mark McCarty
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: GAO says wound care spending dropped between 2016 and 2018; FDA updates COVID testing data; May 2019 Q-sub guidance appears in final form.
Read More
Previous 1 2 … 70 71 72 73 74 75 76 77 78 … 184 185 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing